RAB31 and cervical cancer: Higher expression of RAB31 was significant associated with shorter overall survival in pancreatic cancer [22] and RAB31 knockdown could inhibited the epithelial-mesenchymal transition and cytoskeletal rearrangement in cervical cancer cells [23].